Aimei Health Technology Co. Ltd. Secures $150,000 Promissory Note to Extend Business Combination Timeline
Aimei Health Technology Co. Ltd. has extended its financial agreement by securing a $150,000 extension payment, allowing the company to postpone its business combination deadline to July 6, 2025. This extension, which is the seventh out of a possible 12, was facilitated through an unsecured promissory note issued on June 6, 2025, to Aimei Health Ltd. and United Hydrogen Group Inc., both Cayman Islands-based entities. Each company contributed $75,000 to fund the extension. The promissory note, which bears no interest, is payable upon the completion of Aimei Health's business combination with United Hydrogen. The involved parties have the option to convert the note into private units of Aimei Health prior to the business combination, providing flexibility in the agreement.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aimei Health Technology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-013936), on June 06, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。